Clinical Trials Browser

Colorectal Neoplasms

Pancreatic Neoplasms

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Glioblastoma, Glioma

Endometrial Neoplasms

Peritoneal Neoplasms

Rectal Cancer Patients

Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Glioblastoma

Glioblastoma, Recurrence

Brain Neoplasms

Uterine Cervical Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Breast Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neoplasms, Small Cell Lung Carcinoma

Neoplasms, Unknown Primary

Pancreatic Neoplasms

Adrenocortical Carcinoma

Leukemia, Lymphocytic, Chronic, B-Cell

Head and Neck Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

INAVO-CRC

QUILT-3.088: NANT Pancreatic Cancer Vaccine

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study

DCE-MRI PET Bevacizumab Study in Rectal Cancer

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

PRIMIER

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma

Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer

Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer

Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Pilot Study for Locally Advanced Head and Neck Cancer

Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

SELECT-A

IXO+A in mCRC With Liver-only Metastases

PERIMAX

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Colorectal Cancer RECHALLENGE